4.6 Article

Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Nuclear Receptor SHP, a Death Receptor That Targets Mitochondria, Induces Apoptosis and Inhibits Tumor Growth

Yuxia Zhang et al.

MOLECULAR AND CELLULAR BIOLOGY (2010)

Article Endocrinology & Metabolism

Significance and Mechanism of CYP7a1 Gene Regulation during the Acute Phase of Liver Regeneration

Lisheng Zhang et al.

MOLECULAR ENDOCRINOLOGY (2009)

Article Oncology

Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis

Salvatore Modica et al.

CANCER RESEARCH (2008)

Review Cell Biology

FXR: a metabolic regulator and cell protector

Yan-Dong Wang et al.

CELL RESEARCH (2008)

Editorial Material Oncology

Design and endpoints of clinical trials in hepatocellular carcinoma

Josep M. Llovet et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Article Oncology

Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice

Insook Kim et al.

CARCINOGENESIS (2007)

Article Biochemistry & Molecular Biology

Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro

Andrea De Gottardi et al.

MOLECULAR CANCER (2006)

Review Endocrinology & Metabolism

Transcriptional corepression by SHP:: molecular mechanisms and physiological consequences

A Båvner et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)

Article Biochemistry & Molecular Biology

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

B Goodwin et al.

MOLECULAR CELL (2000)